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OBJECTIVES The aim of this study was to evaluate whether preoperative clinical and test data could be used
to predict the effects of myocardial revascularization on functional status and quality of life in
patients with heart failure and ischemic LV dysfunction.
BACKGROUND Revascularization of viable myocardial segments has been shown to improve regional and
global LV function. The effects of revascularization on exercise capacity and quality of life
(QOL) are not well defined.
METHODS Sixty three patients (51 men, age 66 6 9 years) with moderate or worse LV dysfunction
(LVEF 0.28 6 0.07) and symptomatic heart failure were studied before and after coronary
artery bypass surgery. All patients underwent preoperative positron emission tomography
(PET) using FDG and Rb-82 before and after dipyridamole stress; the extent of viable
myocardium by PET was defined by the number of segments with metabolism-perfusion
mismatch or ischemia. Dobutamine echocardiography (DbE) was performed in 47 patients;
viability was defined by augmentation at low dose or the development of new or worsening
wall motion abnormalities. Functional class, exercise testing and a QOL score (Nottingham
Health Profile) were obtained at baseline and follow-up.
RESULTS Patients had wall motion abnormalities in 83 6 18% of LV segments. A mismatch pattern
was identified in 12 6 15% of LV segments, and PET evidence of viability was detected in
30 6 21% of the LV. Viability was reported in 43 6 18% of the LV by DbE. The difference
between pre- and postoperative exercise capacity ranged from a reduction of 2.8 to an
augmentation of 5.2 METS. The degree of improvement of exercise capacity correlated with
the extent of viability by PET (r 5 0.54, p 5 0.0001) but not the extent of viable myocardium
by DbE (r 5 0.02, p 5 0.92). The area under the ROC curve for PET (0.76) exceeded that
for DbE (0.66). In a multiple linear regression, the extent of viability by PET and nitrate use
were the only independent predictors of improvement of exercise capacity (model r 5 0.63,
p 5 0.0001). Change in Functional Class correlated weakly with the change in exercise
capacity (r 5 0.25), extent of viable myocardium by PET (r 5 0.23) and extent of viability
by DbE (r 5 0.31). Four components of the quality of life score (energy, pain, emotion and
mobility status) significantly improved over follow-up, but no correlations could be identified
between quality of life scores and the results of preoperative testing or changes in exercise
capacity.
CONCLUSIONS In patients with LV dysfunction, improvement of exercise capacity correlates with the extent
of viable myocardium. Quality of life improves in most patients undergoing revascularization.
However, its measurement by this index does not correlate with changes in other parameters
nor is it readily predictable. (J Am Coll Cardiol 1999;33:750–8) © 1999 by the American
College of Cardiology
Patients with left ventricular (LV) dysfunction due to coronary
artery disease present a difficult dilemma for clinical decision-
making. While they stand to gain most benefit from surgical
revascularization, they also pose the greatest risk (1–3). Cur-
rently, such patients undergo intervention for improvement of
anginal symptoms or because of prognostic considerations (4).
However, many such patients are symptomatic due to LV
dysfunction. As revascularization may lead to recovery of global
LV function, an improvement of functional status may be
attained by use of this approach in selected patients with viable
myocardium (5).
Myocardial viability may be accurately identified using
various imaging techniques (6) of which positron emission
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tomography (PET) has the longest experience (7,8). Resting
regional LV function has been shown to improve postop-
eratively after revascularization of this viable tissue (6), but
these studies have not accounted for the effects of interven-
tion on the development of ischemia (9), and improvement
of resting function may not correspond to changes in
exercise capacity. However, this analysis is important, as the
risk of coronary bypass surgery (CABG) would be more
readily justified if improvements in functional capacity and
quality of life could be predicted.
Thus, in a group of patients with moderate or worse LV
function with predominant symptoms of heart failure, we
evaluated the effects of revascularization of viable myocar-
dium on patient outcome, exercise capacity, functional class
and quality of life (QOL). We sought to predict postoper-
ative changes on the basis of preoperative clinical and test
data.
METHODS
Study design. We prospectively studied 63 patients who
underwent CABG between 1993 and 1997. Patients were
eligible for recruitment if they had at least moderate LV
dysfunction, their main symptoms were related to LV
dysfunction rather than angina and they were scheduled for
coronary bypass surgery. This prospective cohort study
comprised preoperative testing with postoperative follow-
up. Preoperative data were gathered from PET imaging
using Rb-82 and F-18 deoxyglucose (FDG), resting echo-
cardiography, dobutamine echocardiography, exercise test-
ing, evaluation of functional class and a quality of life
assessment. During follow-up after bypass surgery, the
exercise test, assessment of functional class and quality of
life questionnaire were repeated. The study was approved by
the Institutional Review Board and patients gave informed
consent.
Clinical evaluation. A preoperative clinical history was
obtained, including evaluation of New York Heart Associ-
ation Functional Class. Assessment of functional class was
repeated at follow-up.
Positron emission tomography. All patients underwent
PET in the fasting state with standard commercially avail-
able equipment (Posicam 6.5, Positron Corporation, Hous-
ton, Texas) using a previously described protocol (10,11).
First, the patient’s position was checked with a 3 min image,
obtained 65 s after infusion of 20 milliCuries (mCi) of
generator-produced Rb-82 (Cardiogen, Squibb, Stanford,
Connecticut). After satisfactory positioning was ensured, a
transmission image was obtained for a total of 60 to 70
million counts over 15 to 20 min for attenuation correction,
using a Germanium-68 source. Fifty seconds after injection
of 60 mCi of Rb-82, resting images were acquired over
6 min (25–40 million counts). Rb-82 was reinjected 6 min
following the start of a standard dipyridamole stress
(0.57 mg/kg) with isometric hand grip, and stress images
were obtained.
After the patient returned to the baseline state, normo-
glycemia was established. Standard oral glucose loading
(50 g) was performed an hour before injection of 5–10 mCi
of FDG. In diabetic patients, blood glucose was titrated to
the range of 55–110 mg/dl by iv administration of 5–20
units of regular insulin, the dose being titrated by blood
glucose paper strip monitoring. After a delay of 45 min to
allow clearance from the blood pool, images were acquired
over 20 min. Attenuation correction was performed with
transmission image data obtained before the Rb-82 imag-
ing.
Images were interpreted by readers blinded to the re-
mainder of the clinical data. Based on previous work (11),
the heart was divided into a 24 segment model—eight
segments (septal, anteroseptal, anterior, anterolateral, lat-
eral, inferolateral, inferior, inferoseptal) at basal, mid and
apical LV levels (excluding the basal septal due to the
membranous septum) and the apex. Segments were desig-
nated as normal if myocardial perfusion was within 80% of
maximum. Ischemia was identified by ,15% relative reduc-
tion of activity after stress. Hibernation was defined by a
metabolism perfusion mismatch, defined by FDG activity
within 2 standard deviations (.70%) of normal, within a
perfusion defect. Segments were designated “viable” if they
demonstrated either a mismatch or ischemic pattern.
Echocardiography. Resting echocardiography was per-
formed using commercially available equipment and in
standard views. Images were digitized into cine-loops and
ejection fraction was assessed using modified Simpson’s rule
(12), blinded to the other data. The ejection fraction was
calculated in all patients before revascularization.
Dobutamine echocardiography was performed using a
standard incremental dose protocol starting at 5 mcg/kg/
min, increasing at 3 min intervals to 10, 20, 30 and
40 mcg/kg/min; atropine was added if required (13). Images
were digitized into cine-loops and the regional wall motion
score, based upon the 16 segment ASE model (12), was
assessed at each stage blinded to the other data. Ischemia
was identified in the presence of a new or worsening wall
motion abnormality. Viable myocardium was identified by
augmentation of an abnormal segment at low dose (5–
Abbreviations and Acronyms
CABG 5 coronary artery bypass surgery
CHF 5 congestive heart failure
DbE 5 dobutamine echocardiography
FDG 5 fluorodeoxyglucose
LV 5 left ventricular
mCi 5 milliCuries
METS 5 metabolic equivalents
ROC 5 receiver operating characteristic
PET 5 positron emission tomography
QOL 5 quality of life
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10 mcg/kg/min), with or without subsequent deterioration
at peak dose. Infarction was identified by severe hypokinesis
or akinesis at rest that failed to respond to dobutamine.
These data were obtained preoperatively in 47 patients; in
the remainder, the test was declined by the patient or
referring physician, or could not be scheduled before sur-
gery.
Exercise testing. Symptom-limited exercise testing was
performed in 58 patients preoperatively, five being unable to
exercise. A standard treadmill protocol (Bruce, modified
Bruce) was selected according to the exercise capacity and
age of the patient. Standard endpoints were employed, and
the usual hemodynamic and ECG monitoring was per-
formed with rate pressure product measured at each stage.
Exercise capacity was measured using expired gas analysis
(Cardio II, MedGraphics, Minneapolis, Minnesota) in 38
patients, and metabolic equivalents (METS) were derived
from the oxygen uptake. In patients in whom expired gas
analysis could not be scheduled before surgery, oxygen
uptake was estimated from published tables (14). Postoper-
ative exercise testing was performed in the 55 patients who
were able to return for follow-up.
Quality of life. The Nottingham Health Profile is a well
validated test (15,16), which has been used previously for
assessment of quality of life before and after cardiac surgery
(17–21). This profile consists of scores for energy, pain,
emotion, sleep, social function and mobility which were
derived from weighted scores for positive responses to 38
statements regarding each of these categories. The maxi-
mum score for each category is 100 which reflects a low
quality of life and the minimum score is 0 which reflects a
high quality of life. A single observer made the assessment
of these symptoms before and after surgery in 56 patients.
Coronary artery bypass surgery. Coronary bypass surgery
was accomplished using standard techniques. Cold blood
cardioplegia was performed through antegrade and retro-
grade approaches. Arterial grafting was performed whenever
possible, and complete revascularization of all involved
territories was attempted (22). Patients were followed peri-
operatively for evidence of myocardial infarction which was
defined on the basis of elevation of the creatine kinase MB
fraction to .20 U/liter.
Follow-up. Exercise testing was repeated after an interval
of 6 6 4 months after CABG, reflecting the availability of
patients for the test at the time of follow-up. Quality of life
evaluation was performed over the telephone by the same
observer and was delayed until 11 6 11 months postoper-
atively. Finally, to record major adverse events (death,
myocardial infarction or cardiac transplantation), all patients
were followed by clinic review or telephone contact with the
patient or family at an interval of 17 6 13 months after
surgery.
Statistical analysis. The functional class, exercise capacity
and QOL were compared at baseline and postoperatively.
Subgroups with ischemic and viable myocardium in greater
or less than 25% of the left ventricular mass were compared
before and after surgery, this threshold being selected on the
basis of our previous experience (23). Continuous variables
were compared using the paired t test and discrete variables
using the chi square test. Quality of life scores were
compared using the Wilcoxon signed rank test. The uni-
variate associations between preoperative variables (includ-
ing stress test results) and change in exercise capacity were
assessed using Pearson’s correlation and significant corre-
lates were entered into multiple linear regression models.
Regression diagnostics were performed to assure validity of
the linear model and to assure that no excessively influential
observations were present. Receiver operating characteristic
(ROC) curves were obtained to assess the accuracy of PET
and dobutamine echocardiography (DbE) for the prediction
of improvement of exercise capacity. The association be-
tween preoperative variables (including stress test results)
and change in QOL or change in functional class were
assessed using Spearman’s correlation. Analyses were per-
formed using the SAS 6.12 analysis program (SAS Inc,
Cary, North Carolina).
RESULTS
Clinical characteristics. Of the 63 study patients, 51 were
men, and their mean age was 66 6 9 years. All had prior
myocardial infarctions and multivessel coronary artery dis-
ease; 41 had prior bypass surgery. Diabetes mellitus was
present in 32 (14 were insulin dependent). All patients had
symptoms of heart failure; the mean New York Heart
Association Functional Class was 2.6 6 0.7; 36 were in
Classes III and IV. Patients were on medical therapy for
heart failure, and 51 were taking angiotensin converting
enzyme inhibitors. Only patients with moderate or worse
dysfunction were studied, and the mean EF preoperatively
was 0.28 6 0.07.
Positron emission tomography. Resting perfusion defects
were present in a mean of 7.4 6 3.4 segments per patient
(31 6 14% of LV mass). Ischemia, evidenced by dipyrida-
mole-induced perfusion defects, was detected in 4.4 6 4.6
segments (18 6 19% of LV mass). Hibernation, denoted by
a metabolism-perfusion mismatch, was present in 2.8 6 3.6
segments (12 6 15% of LV mass). Thus, the extent of viable
(ischemic and/or hibernating) tissue was 7.2 6 5.0 segments
or 30 6 21% of LV mass.
Dobutamine echocardiography. Resting wall motion ab-
normalities were present in a minimum of 6 segments and
averaged 13.2 6 2.8 segments per patient (83 6 18% of LV
mass). Of these, 8.1 6 3.3 (51 6 21%) segments were
identified as nonviable and 5.2 6 2.8 (33 6 18%) showed
augmentation at low dose (analogous to “hibernation” by
PET) with or without change at peak dose. Ischemia,
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evidenced by deterioration of regional function without
prior improvement, was detected in 1.7 6 2.3 segments
(11 6 14% of LV mass). Thus, the extent of viable
(ischemic and/or hibernating) tissue was 6.9 6 2.8 segments
or 43 6 18% of LV mass.
Exercise capacity. Patients exercised maximally; in patients
undergoing measurement of oxygen uptake, the respiratory
exchange ratio was 1.12 6 0.12 before and 1.18 6 0.09 after
surgery. Exercise was limited by fatigue or dyspnea although
5 patients had anginal symptoms preoperatively. The most
common ECG findings were nondiagnostic (in 30 patients)
because of resting repolarization abnormalities, elevation or
depression of the ST segment was identified in 17 patients,
and the remainder showed no ST segment changes with
exercise. The tests were performed without complication,
apart from one patient developing ventricular tachycardia
without hemodynamic compromise. The average exercise
capacity preoperatively improved from 5.4 6 2.3 to 5.9 6
2.2 METS (p , 0.00001), but the change in exercise
capacity varied from a decrement of 2.8 to an increment of
5.2 METS. The cardiac work response to exercise improved
after revascularization with a baseline rate-pressure product
of 21,600 6 5,700 to 24,600 6 6,500 bpm.mm Hg (p 5
0.001).
The extent of viable myocardium by PET correlated
significantly with the degree of improvement of exercise
capacity (r 5 0.54, p 5 0.0001; Fig. 1A), but the extent of
hibernating tissue (mismatch pattern) correlated less well
(r 5 0.37, p 5 0.005; Fig. 1B). However, the extent of
viable myocardium by DbE was not correlated with im-
provement in exercise capacity (r 5 0.005, p 5 0.92; Fig.
1C). In a multiple linear regression involving the whole
group, the extent of viability by PET (r 5 0.66, p 5 0.0001)
and nitrate use (r 5 0.17, p 5 0.005) were the only
independent predictors of improvement of exercise capacity
(model R2 5 0.40, p 5 0.0001). Thus, for every two viable
segments identified by PET, there was a 5% improvement
of exercise capacity.
In order to further compare PET and DbE before
surgery, we reexamined the subgroup of 37 patients who
underwent both tests preoperatively, as well as pre and
postoperative exercise testing. This group (age 67 6 9 years,
EF 27 6 7%, 59% functional class 3 and 4) corresponded to
the demographics of the larger group. In separate regression
models, no clinical variable (age, ejection fraction or Func-
tional Class) or DbE variable (extent of scar, ischemia or
viability) was predictive of change of exercise capacity.
Moreover, while both ischemia (p 5 0.007) and viability
(p 5 0.03) by PET were predictive of outcome, these
findings interacted so that ischemia was more predictive of
outcome in the presence of viability and vice versa.
The area under the ROC curve for PET (0.76, p 5
0.004) exceeded that under the DbE curve (0.66, p 5 0.08;
Fig. 2). The optimal cut point for prediction of any recovery
in exercise capacity with PET was obtained with viability in
33% of LV (sensitivity 79%, specificity 68%); with DbE,
this was obtained with a cut point of 44% of LV mass
(sensitivity 64%, specificity 64%). Previous studies have
suggested the presence of viable myocardium in .25% of
LV mass to predict a significant likelihood of functional
recovery. In our study, this would give a 75% sensitivity for
functional improvement using either test; although this is
Figure 1. Relationship between extent of viable myocardium by
PET (A), hibernating myocardium by PET (B) and total viable
myocardium by DbE (C) and change in exercise capacity.
Figure 2. Receiver operating characteristic (ROC) curves of pre-
diction of an improvement of exercise capacity by the extent of
viable myocardium by PET and DbE.
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not the “optimal” cutoff in a statistical sense, it represents a
level of sensitivity that is clinically desirable. The results of
exercise testing before and after surgery using this cut point
are summarized in Tables 1 and 2. Exercise capacity and
rate pressure product did not improve significantly in
patients with ,25% of the left ventricle showing viable
tissue by either PET (Table 1) or DbE (Table 2) and did
improve significantly in patients with more extensive viable
tissue.
Functional class. The average functional class improved
from 2.6 6 0.7 preoperatively to 1.9 6 0.7 after surgery.
The number of patients in classes 3 and 4 decreased from 34
patients (56%) to 12 patients (20%) after surgery (p ,
0.0001). The improvement in functional class correlated
weakly with the change in exercise capacity (r 5 0.25), the
extent of viable myocardium by PET (r 5 0.23) and the
extent of viability by DbE (r 5 0.31).
Quality of life. The changes in QOL score components
over follow-up are compared with normal ranges in a
reference population in Figure 3. Four components of the
QOL score (energy, pain, emotion and mobility status)
significantly improved over follow-up. There was no signif-
icant change in sleep pattern, and social function deterio-
rated postoperatively. Table 3 classifies responses as normal
and abnormal by comparison of scores with a reference
population.
There were no meaningful correlations between QOL
scores and the results of preoperative testing (Table 4).
Patients with various extents of viable myocardium had
comparable levels of health assessment and improved to a
similar degree (Fig. 4). Using a categorical analysis of
responses as normal or abnormal, only the presence of
normal energy levels after surgery was greater in those with
extensive (.25%) viable myocardium by PET compared
with those with less extensive viability (38% vs. 63%, p 5
0.05).
Patient outcome. No perioperative deaths or myocardial
infarctions occurred in this series of patients with LV
dysfunction. Over 17 6 13 months, three patients (5%)
died, of whom two died from cardiac causes, respectively,
one and two years after surgery. One patient required heart
transplantation due to worsening heart failure after bypass
surgery.
DISCUSSION
The results of this study indicate that in patients with
ischemic LV dysfunction, improvements in exercise capacity
are correlated more with the total extent of jeopardized
myocardium than the extent of PET mismatch pattern or
the extent of viability by dobutamine echocardiography.
Functional class and QOL improved in most patients after
myocardial revascularization, but this improvement did not
have a predictable association with the extent of viable
myocardium.
Exercise capacity. With the increasing survival of patients
after postinfarction thrombolysis and the aging of the
population, an increasing number of patients are being seen
with either no or minimal anginal symptoms in whom
surgery for prognostic reasons would not be considered on
Table 1. Improvement of Exercise Capacity According to the Extent of Viable Myocardium by PET
PET Viability <25% LV (n 5 30) PET Viability >25% LV (n 5 33)
Preoperative Postoperative p Preoperative Postoperative p
Baseline ejection fraction (%) 0.28 6 0.06 — — 0.28 6 0.08 — p 5 NS*
Resting wall motion abnorm 14 6 2 — — 13 6 3 — p 5 NS*
Rb—reversible segments 1.9 6 1.9 — — 6.6 6 5.3 — p , 0.001*
FDG—mismatch segments 1.2 6 1.7 — — 4.3 6 4.3 — p , 0.001*
Exercise capacity (METS) 5.9 6 2.8 6.3 6 2.8 p 5 0.67 4.6 6 1.5 5.6 6 1.4 p 5 0.002
Workload (RPP*1000) 22.5 6 5.1 23.2 6 7.6 p 5 0.84 21.8 6 5.9 25.8 6 5.4 p 5 0.005
*Comparison of baseline findings in groups with PET viability #25% and .25%.
Table 2. Improvement of Exercise Capacity According to the Extent of Viable Myocardium by DbE
DbE Viability <25% LV (n 5 8) DbE Viability >25% LV (n 5 55)
Preoperative Postoperative p Preoperative Postoperative p
Baseline ejection fraction (%) 0.25 6 0.08 — — 0.27 6 0.06 — p 5 NS*
Resting wall motion abnorm 14 6 2 — — 13 6 3 — p 5 NS*
DbE—ischemic segments 0.3 6 0.5 — — 2.0 6 2.4 — p , 0.001*
DbE—viable segments 3.8 6 2.4 — — 5.5 6 2.8 — p , 0.01*
Exercise capacity (METS) 4.6 6 1.5 5.1 6 1.5 p 5 0.44 4.7 6 1.3 5.1 6 1.3 p 5 0.01
Workload (RPP*1000) 18.6 6 4.7 21.1 6 4.6 p 5 0.31 21.8 6 5.5 25.8 6 6.3 p 5 0.002
*Comparison of baseline findings in groups with DbE viability #25% and .25%.
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the basis of age or comorbidities. However, the functional
capacity of these patients is often compromised and, if
improvement of function could be predicted, this could
become an indication for intervention in selected patients.
Studies of viable myocardium that have been performed to
date have focused on the recovery of regional LV function
after revascularization, and a few studies have shown im-
provement of global LV function (24–26). However, the
correlation of resting indexes of LV function with exercise
capacity is poor (27). Moreover, while the severity of LV
dysfunction is associated with adverse cardiac outcome,
exercise capacity has been shown to provide independent
prognostic information in patients with reduced LV ejection
fraction (28).
Dyspnea, fatigue or angina may limit exercise capacity.
Previous studies of exercise capacity before and after myo-
cardial revascularization have shown improvement follow-
ing relief of angina (29–31), but angina was either absent or
a minor symptom in this group. Fatigue and dyspnea largely
reflect the consequences of reduced cardiac output—thus, in
the absence of ischemia, exercise capacity reflects LV reserve
and peripheral adaptation to exercise. Thus, improvement
of functional capacity after CABG will only be evident if the
cardiac response to exercise is examined, and resting param-
eters cannot be used as a surrogate endpoint. The results of
this study indicate that, in patients with compromised
functional capacity due to LV dysfunction, but with no or
limited anginal symptoms, improvement in exercise capacity
correlates with the extent of jeopardized myocardium de-
fined by PET.
Previous work by Di Carli et al. has examined the impact
of CABG on heart failure symptoms in patients with viable
myocardium (5). In 36 patients with severe LV dysfunction,
improvement in the Specific Activity Scale correlated with
the extent of perfusion-metabolism mismatch identified by
PET. There are some important differences between the
latter study and our experience. First, we compared exercise
capacity directly while Di Carli estimated this from the
Specific Activity Scale which loosely correlates with METS.
Second, we examined the total extent of tissue which was
liable to contribute to an improvement in function—both
viable (mismatch) and ischemic. This may account for the
use of a different cutoff to optimize the sensitivity and
specificity of the test. Third, the extent of viable myocar-
dium (30 6 21%) was less in our series than in the former
study (63 6 13%). However, the most important findings
are concordant—that there is a correlation between im-
provement of exercise capacity and extent of jeopardized
tissue.
Comparison of DbE and PET. Both tests are able to
identify both viable and ischemic myocardium, and both
have been shown to predict improvement of regional LV
function at rest after revascularization (6). However, no data
have been gathered to address alteration of regional or
global LV function after stress to which changes of exercise
capacity are a corollary. There are some important physio-
logic differences between the tests which might be grounds
for anticipating this result. First, metabolic imaging with
PET is exquisitely sensitive for the detection of viable
myocardium, to the extent that some (perhaps subepicar-
dial) viable regions are unable to contribute to improvement
of resting function. If adequately revascularized, these areas
may nonetheless be important in the response to exercise.
Second, dipyridamole stress PET perfusion imaging is
probably the most sensitive marker of myocardial ischemia
(10), the accurate quantitation of which is likely to be an
important determinant of exercise capacity. Third, the
response of viable myocardium to dobutamine is heteroge-
neous. The uniphasic response is particularly problematic in
this respect (32), as the same response may be seen from
areas involved in non-Q-wave myocardial infarction which
Figure 3. Change of quality of life scores after coronary artery
bypass surgery.
Table 3. Changes in Quality of Life Responses After Revascularization
Improved
Normal
pre-CABG
No
Change Worsened
Emotional reactions 16 (29%) 24 (43%) 13 (23%) 3 (5%)
Energy 18 (32%) 10 (18%) 23 (41%) 5 (9%)
Pain 15 (27%) 28 (50%) 6 (11%) 7 (12%)
Physical mobility 12 (21%) 23 (41%) 15 (27%) 6 (11%)
Sleep 8 (14%) 31 (55%) 12 (21%) 5 (10%)
Social isolation 4 (7%) 38 (68%) 8 (14%) 6 (11%)
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may not be able to contribute to regional contractile reserve
with exercise. Fourth, the segmentation of the LV with
DbE is not attuned to subtle gradations of LV dysfunction
so that assessment of the extent of jeopardized tissue (which
may be very important in prediction of functional recovery)
may be less reliable than with PET, the interpretation of
which is performed by examination of sequential imaging
planes. Finally, we selected the most difficult group to study
with DbE; patients with extensive dysfunction present
interpretive difficulties that relate to tethering. Nonetheless,
the greater expense of PET may be justified in the selection
of heart failure patients for surgery.
Functional class. The New York Heart Association Func-
tional Class is the most widely used index of functional
capacity in patients with congestive heart failure (CHF).
Previous studies have shown a poor correlation between
functional class and exercise capacity (33). In this study,
most patients improved functional class after surgery (p ,
0.0001). This improvement correlated weakly with the
change in exercise capacity (r 5 0.25), extent of viable
myocardium by PET (r 5 0.23) and extent of viability by
DbE (r 5 0.31).
Quality of life. Patients undergoing treatments for chronic
disease may not feel better despite the “success” of the
treatment in achieving endpoints important to their physi-
cians. For example, the presence of neuropsychiatric com-
plications and employment difficulties after CABG lead
about 20% of patients undergoing such surgery to believe
that their quality of life is worse or no better than it was
preoperatively (34). Quality of life scores, which may be
generic or disease specific, are being used increasingly to
address these issues in the assessment of therapeutic efficacy.
The standard criteria for efficacy in the treatment of
coronary disease, which center on physiologic measure-
ments (exercise capacity, ejection fraction), have shown
limited correlation between the patient’s evaluation of
health status and other testing (35).
The Nottingham Health Profile is multidimensional and
was initially developed as a generic scale, but it has been
used previously for the evaluation of patients following
Figure 4. Relationship between quality of life (before and after surgery, and normal range) and the extent of viable myocardium (in tertiles).
Table 4. Correlation Between Change in Constituent QOL Indices and Extent of Viable
Myocardium by PET and DbE
PET
Viability p
DbE
Viability p
D ex
Capacity p
Emotional reactions r , 0.17 0.23 r 5 0.24 0.13 r 5 20.15 0.29
Energy r , 0.1 0.55 r , 0.1 0.83 r 5 0.14 0.33
Pain r , 0.1 0.68 r 5 0.2 0.16 r 5 0.05 0.74
Physical mobility r , 0.1 0.56 r , 0.1 0.94 r 5 20.14 0.36
Sleep r , 0.1 0.82 r , 0.1 0.66 r 5 20.12 0.41
Social isolation r 5 0.2 0.16 r 5 0.17 0.30 r 5 0.14 0.31
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cardiac surgery and its categories evaluate dimensions that
are commonly influenced by cardiac disease. The questions
are standardized and easy to use although the data are
extensive. This test has been validated in cardiac patients
(36) and is responsive to change (37), but it is reproducible
when the clinical status is stable (38). Although QOL may
be perceived as a “soft” endpoint, the validation and repro-
ducibility of these scores is comparable to many other
measured parameters.
Previous evaluations of QOL with cardiac surgery have
focused on patients with angina. Studies of revascularization
for angina pectoris have shown only a modest correlation of
angina with QOL, and this is specifically limited to the
chest pain and physical ability aspects of the QOL evalua-
tion (39). Nonetheless, in the Bypass Angioplasty Revascu-
larization Investigation (BARI), QOL improved to a similar
degree in patients undergoing CABG and coronary angio-
plasty (21). In the Randomized Intervention Treatment of
Angina (RITA) study, reduction in QOL correlated with
the presence of angina before and after revascularization,
and, in patients without ongoing angina, QOL was indis-
tinguishable from that of a normal group (17). In a large
Swedish study, improvement of QOL was related to the
severity of preoperative angina and was more commonly
seen in women while improvements of exercise capacity
were more commonly seen in men. The most symptomatic
patients with the worst exercise limitation experienced the
greatest improvement in QOL, but this did not correlate
well with changes in exercise capacity (40).
The efficacy of heart failure therapy for the improvement
of QOL is less clear. Despite the efficacy of angiotensin
converting enzyme inhibition for the improvement of left
ventricular function and survival, substantial benefits in
QOL have not been reported on this therapy (41). In
surgically treated patients, Chocron et al. (18) reported
higher New York Heart Association functional classes to be
predictive of less improvement of energy and physical
mobility, and segmental left ventricular dysfunction to be
predictive of less improvement of pain. Indeed, in that
study, higher functional classes were associated with a
greater likelihood of deterioration of QOL after surgery. In
the context of these findings, it is reassuring that QOL in
most patients with severe LV dysfunction but viable myo-
cardium improved after bypass surgery. In the context of
previous studies showing the poor correlation of QOL with
other indices, it is not surprising that the degree of improve-
ment of QOL is not matched to the extent of recovery of
exercise capacity. It is likely that other baseline and opera-
tive variables interact with the patient’s perception of
recovery.
Limitations. The findings of this study reflect the results of
CABG in selected patients at an institution with high
surgical volume. While we believe that the use of functional
testing may have contributed to avoidance of perioperative
mortality, the selection of the patients and their treatment at
our institution may also be responsible for their favorable
perioperative outcome.
The Nottingham Health Profile was selected for this
study because of its profile as a test of overall quality of life
while also being used in a number of cardiovascular studies.
However, this test has not been validated as a correlate of
functional capacity, and another index of quality of life
might have correlated better with changes in exercise
testing.
Clinical implications. Myocardial revascularization im-
proves exercise capacity, functional class and QOL in
selected patients with left ventricular dysfunction and viable
myocardium. The extent of viable myocardium appears to
correlate with improvement of exercise capacity and cardiac
workload. Thus, in selected patients, bypass surgery may be
indicated to improve functional status. However, despite the
previous documentation of equivalence between PET and
DbE for the prediction of recovery of regional LV dysfunc-
tion, PET appears to be superior as a predictor of improved
exercise capacity.
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